Selective Complex Fractionated Atrial Electrograms (CFAE) Targeting for Atrial Fibrillation
Clinical trial NCT00926783 · COMPLETED
Trial details
- NCT number
- NCT00926783
- Sponsor
- Biosense Webster, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-11-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.